ARS Pharmaceuticals has an Enterprise Value (EV) of 971.91M.
10.9
-338.05
71.74
74.85
Financial Position
The company has a current ratio of 14.26,
with a Debt / Equity ratio of 0.
14.26
14.04
0
-0.01
n/a
0
Financial Efficiency
Return on Equity is 3.11% and Return on Invested Capital is -0.91%.
3.11%
2.28%
-0.91%
$575.15K
$51.6K
155
0.25
0.19
Taxes
288K
3.48%
Stock Price Statistics
The stock price has increased by -9.02% in the
last 52 weeks. The beta is 0.92, so ARS Pharmaceuticals's
price volatility has been higher than the market average.
0.92
-9.02%
16.21
13.83
22.01
1,793,364
Income Statement
In the last 12 months, ARS Pharmaceuticals had revenue of 89.15M
and earned 8M
in profits. Earnings per share was 0.08.